Due to the technical limitations of the positive immunoselection-based methods, as mentioned above, the development of a protocol that can obtain the possible CTCs without depending on tumor-associated cell surface antigens, such as EpCAM or CKs, is crucial. Here, EPCAM is linked to neoplasm.